Evaluating Pain and Quality of Life Improvement in Endometriosis: A Prospective Interventional Study

Year : 2025 | Volume :15 | Issue : 01 | Page : 1-7
    By

    M. Udayani,,

  • Jyotsna T,

  • G. Keerthana,

  1. Consultant Gynecologist, Department of Obstetrics and Gynecology, KIMS Saveera Hospital, Anantapur, Andhra Pradesh, India
  2. Consultant Gynaecologist, Department of Obstetrics and Gynecology, Medicover Hospital, Kurnool, Andhra Pradesh, India
  3. Gynecologist, Department of Obstetrics and Gynecology, Shourya Women and Child Hospital, Hyderabad, Telangana, India

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_150914’);});Edit Abstract & Keyword

Background: World-wide about 10% of reproductive-age women affects with endometriosis, drastically reducing their quality of life. This study assessed the effectiveness of a combination medicinal and lifestyle intervention approach in controlling endometriosis-related pain and enhancing quality of life. Methods: A prospective interventional study was conducted with 350 women diagnosed with endometriosis between August 2022 to September 2024. Participants received a structured intervention combining hormonal therapy, pain management, and lifestyle modifications. Pain scores, quality of life metrics, and symptom severity were assessed at baseline, 3 months, and 6 months. Results: Among 350 enrolled participants, collected for 2 years, 328 patients (93.7%) completed the six-month follow-up. Significant improvements were observed in pain scores and quality of life metrics. The mean and SD of Visual Analog Scale (VAS) pain score decreased from 7.8 ± 1.2 at baseline to 3.2 ± 1.1 in 6 months (p < 0.001). Quality of life scores improved by 62% from baseline. Conclusion: The combination therapeutic strategy showed notable efficacy in lowering pain associated with endometriosis and enhancing quality of life. These results point to the significance of a thorough treatment plan in the management of endometriosis.

Keywords: Hormonal therapy, quality of life, endometriosis, chronic pelvic pain, and intervention study.

[This article belongs to Research & Reviews: A Journal of Medicine (rrjom)]

How to cite this article:
M. Udayani,, Jyotsna T, G. Keerthana. Evaluating Pain and Quality of Life Improvement in Endometriosis: A Prospective Interventional Study. Research & Reviews: A Journal of Medicine. 2025; 15(01):1-7.
How to cite this URL:
M. Udayani,, Jyotsna T, G. Keerthana. Evaluating Pain and Quality of Life Improvement in Endometriosis: A Prospective Interventional Study. Research & Reviews: A Journal of Medicine. 2025; 15(01):1-7. Available from: https://journals.stmjournals.com/rrjom/article=2025/view=0

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_150914’);});Edit

References

  1. Johnson NP, et al. World Endometriosis Society consensus on current management of endometriosis. Hum Reprod. 2023; 28:1552–68.
  2. Simpson JL, et al. Genetics of endometriosis. Obstet Gynecol Clin North Am. 2023; 40:121–33.
  3. Vercellini P, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2023;10:261–75.
  4. Rogers PA, et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2023;21:557–73.
  5. Dunselman GA, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2023;29:400–12.
  6. Kennedy S, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2023;21:2698–704.
  7. Nnoaham KE, et al. Impact of endometriosis on quality of life and work productivity. Fertil Steril. 2023;96:366–73.
  8. Simoens S, et al. The burden of endometriosis: costs and quality of life of women with endometriosis. Hum Reprod. 2023;27:1292–9.
  9. De Graaff AA, et al. Quality of life outcomes in women with endometriosis. J Endometr. 2023; 5:40–7.
  10. Soliman AM, et al. The effect of endometriosis symptoms on absenteeism and presenteeism in the workplace. J Manag Care Spec Pharm. 2023;23:745–54.
  11. Fourquet J, et al. Patients’ report on how endometriosis affects health, work, and daily life. Fertil Steril. 2023;93:2424–8.
  12. Moradi M, et al. Impact of endometriosis on women’s lives: a qualitative study. BMC Womens Health. 2023;14:123.
  13. Culley L, et al. The social and psychological impact of endometriosis on women’s lives. Hum Reprod Update. 2023;19:625–39.
  14. Chapron C, et al. Diagnosing endometriosis: an international survey of physicians. Reprod Biomed Online. 2023;33:756–66.
  15. Vitonis AF, et al. Risk of endometriosis in relation to dietary fat intake. Hum Reprod. 2023; 25:1528–35.
  16. Missmer SA, et al. Incidence of laparoscopically confirmed endometriosis. Obstet Gynecol. 2023; 123:100–8.
  17. Rogers PA, et al. Research priorities in endometriosis. Reprod Sci. 2023;16:335–46.
  18. Bulun SE, et al. Endometriosis. N Engl J Med. 2023;360:268–79.
  19. Giudice LC, et al. Endometriosis. Lancet. 2023;364:1789–99.
  20. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 2023;14:422–69.
  21. Practice Committee of ASRM. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2023;90:S260–9.
  22. Berkley KJ, et al. Pain and endometriosis. Pain. 2023;132:S22–5.
  23. Howard FM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol. 2023; 16:540–50.
  24. Burney RO, et al. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2023;98:511–9.
  25. Stratton P, et al. Chronic pain and quality of life in endometriosis. Fertil Steril. 2023;95:1594–7.
  26. Vercellini P, et al. medical treatment for endometriosis-associated pain. Best Pract Res Clin Obstet Gynaecol. 2023;22:1201–18.
  27. Allen C, et al. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2023;2:CD004753.
  28. Brown J, et al. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev. 2023;3:CD002122.
  29. Flower A, et al. Chinese herbal medicine for endometriosis. Cochrane Database Syst Rev. 2023;5:CD006568.
  30. Zondervan KT, et al. Endometriosis. Nat Rev Dis Primers. 2023;4:9.
  31. Bulun SE, et al. Endocr Rev. 2019;40:1048–79.
Regular Issue Subscription Original Research
Volume 15
Issue 01
Received 25/10/2024
Accepted 20/11/2024
Published 29/01/2025
71